Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-21-021177
Filing Date
2021-08-25
Accepted
2021-08-25 08:58:27
Documents
26

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 2696043
2 ex5-1.htm EX-5.1 24211
3 ex23-2.htm EX-23.2 4630
4 logo_001.jpg GRAPHIC 7906
5 image_002.jpg GRAPHIC 144198
6 image_003.jpg GRAPHIC 194757
7 image_004.jpg GRAPHIC 180739
8 image_005.jpg GRAPHIC 63267
9 image_006.jpg GRAPHIC 262529
10 figure02_01.jpg GRAPHIC 268196
11 figure03_01.jpg GRAPHIC 325033
12 figure04_01.jpg GRAPHIC 176854
13 figure05_01.jpg GRAPHIC 190604
14 figure07_01.jpg GRAPHIC 189782
15 figure08_01.jpg GRAPHIC 120168
16 figure11_01.jpg GRAPHIC 174005
17 figure13_01.jpg GRAPHIC 103898
18 figure14_01.jpg GRAPHIC 102828
19 figure15_01.jpg GRAPHIC 96511
20 figure16_01.jpg GRAPHIC 83018
21 figure17_01.jpg GRAPHIC 82111
22 figure18_01.jpg GRAPHIC 106743
23 figure19_01.jpg GRAPHIC 89753
24 figure20_01.jpg GRAPHIC 97710
25 figure21_01.jpg GRAPHIC 90793
26 figure22_01.jpg GRAPHIC 120336
  Complete submission text file 0001493152-21-021177.txt   7233497
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-258071 | Film No.: 211204056
SIC: 2834 Pharmaceutical Preparations